Chromocell Therapeutics Corp(CHRO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CHRO Chromocell Therapeutics Corp

Market Closed 07-01 16:00:00 EDT

13.50

+0.00

0.00%

High13.50	Low13.50	Vol0.00
Open13.50	D1 Closing13.50	Amplitude0.00%
Mkt Cap87.55M	Tradable Cap33.89M	Total Shares6.49M
T/O253.52K	T/O Rate0.00%	Tradable Shares2.51M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CHRO","market":"US","secType":"STK","nameCN":"Chromocell Therapeutics Corp","latestPrice":13.5,"timestamp":1751400000000,"preClose":13.5,"halted":8,"volume":0,"delay":0,"floatShares":2510100,"shares":6485007,"eps":-1.240475,"marketStatus":"Market Closed","change":0,"latestTime":"07-01 16:00:00 EDT","open":13.5,"high":13.5,"low":13.5,"amount":253515.31479180002,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.240475,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"symbolChange":{"newSymbol":"PTHS","executeDate":"2025-07-02"},"adr":0,"listingDate":1708059600000,"exchange":"AMEX","adjPreClose":13.5,"volumeRatio":0},"requestUrl":"/m/hq/s/CHRO","defaultTab":"news","newsList":[{"id":"2546171741","title":"Channel Therapeutics to Implement 10-for-1 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2546171741","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546171741?lang=en_us&edition=fundamental","pubTime":"2025-06-27 21:51","pubTimestamp":1751032290,"startTime":"0","endTime":"0","summary":"Channel Therapeutics  said Friday it will implement a 10-for-one reverse split of its common shares.The reverse stock split is intended to increase the market price of the company's common shares and help it satisfy the initial listing requirements of the NYSE American in connection with the expected closing of the merger between its CHRO Merger Sub unit and Ligand Pharmaceutical's  LNHC subsidiary.The reverse stock split is expected to be effective before markets open on July 1. Once effective, the reverse stock split is expected to reduce the company's issued and outstanding shares to about 648,501 shares from about 6.5 million shares.Price: 1.47, Change: +0.30, Percent Change: +25.64","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4139","LENZ","BK4539","CHRO","LU0566484027.USD","LU1559883803.SGD","PTHS","LGND"],"gpt_icon":0},{"id":"2546749301","title":"BRIEF-Channel Therapeutics Announces Reverse Stock Split as Merger with Pelthos Closes and $50.1M Private Placement Completes","url":"https://stock-news.laohu8.com/highlight/detail?id=2546749301","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546749301?lang=en_us&edition=fundamental","pubTime":"2025-06-27 21:17","pubTimestamp":1751030243,"startTime":"0","endTime":"0","summary":"BRIEF-Channel Therapeutics Announces Reverse Stock Split as Merger with Pelthos Closes and $50.1M Private Placement CompletesJune 27 (Reuters) - Channel Therapeutics Corp CHRO.A:CHANNEL THERAPEUTICS A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nTUA8QLCVM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHRO","PTHS","BK4139"],"gpt_icon":0},{"id":"2546498077","title":"Channel Therapeutics Corp - Announces 10-for-One Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2546498077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546498077?lang=en_us&edition=fundamental","pubTime":"2025-06-27 21:15","pubTimestamp":1751030100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nTUA8QLCVM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CHRO","BK4139","PTHS"],"gpt_icon":0},{"id":"2545041555","title":"Press Release: TransUnion Appoints Alicia Zuiker Chief Human Resources Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2545041555","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545041555?lang=en_us&edition=fundamental","pubTime":"2025-06-23 18:55","pubTimestamp":1750676100,"startTime":"0","endTime":"0","summary":"CHICAGO, June 23, 2025  -- Alicia Zuiker has joined TransUnion  as Executive Vice President, Chief Human Resources Officer , effective June 23, 2025.Zuiker is an accomplished CHRO with deep experience leading global talent strategies across a range of relevant industries including financial services, digital enablement and technology. Her leadership has helped both mature and entrepreneurial companies achieve transformation and growth. In her new role at TransUnion, she will oversee TransUnion's Human Resources and Communications functions, reporting to TransUnion President and CEO Chris Cartwright and serving on the executive leadership team.Most recently, Zuiker served as Chief People Officer for Lyft. Prior to that, she served as Chief People Officer for Visby Medical and helped Google evolve the people function for Google Cloud. She began her career with 14 years at GE in a series of HR leadership roles. She holds a master's degree in human resource management from Purdue Universit","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ23171101.USD","LU1989764748.USD","LU1169589451.USD","BK4604","BK4588","BK4232","BK4555","PTHS","SG9999004303.SGD","LU1989764664.SGD","TM","03160","BK4585","BK4123","BK4022","R","LU1169590202.USD","TRU","BK4139","BK4099","CHRO"],"gpt_icon":0},{"id":"2542131223","title":"Press Release: Goosehead Insurance Names Angie Kervin as Chief Human Resources Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2542131223","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542131223?lang=en_us&edition=fundamental","pubTime":"2025-06-10 21:00","pubTimestamp":1749560400,"startTime":"0","endTime":"0","summary":"WESTLAKE, Texas, June 10, 2025  -- Goosehead Insurance, Inc., , a rapidly growing, independent personal lines insurance agency, has appointed Angie Kervin as Chief Human Resources Officer . With more than two decades of experience leading human capital strategies across large, distributed workforces, Kervin will spearhead Goosehead's efforts to enhance its HR capabilities, further solidifying its position as an industry leader.\"Angie's deep expertise and track record of driving innovation and excellence position her perfectly to lead our HR efforts,\" said Mark Miller, President and Chief Executive Officer of Goosehead Insurance. \"Our ability to attract, develop and retain exceptional human capital has always been a cornerstone of our success. Angie's strategic vision and leadership will further enhance this advantage, helping us push boundaries and foster a dynamic, forward-thinking culture that drives growth and excellence at every level.\". \"I am thrilled to join Goosehead Insurance a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSHD","BK4173","CHRO","BK4139"],"gpt_icon":0},{"id":"2535589026","title":"Channel Therapeutics Corp - Achieves Endpoints in Pre-Clinical Models for Ct2000","url":"https://stock-news.laohu8.com/highlight/detail?id=2535589026","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535589026?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:00","pubTimestamp":1747224002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA52WRN8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CHRO"],"gpt_icon":0},{"id":"2535482025","title":"Channel Therapeutics Announces Positive Efficacy Results for the Treatment of Eye Pain Using Its Nav1.7 Inhibitor in Multiple Preclinical in Vivo Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2535482025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535482025?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:00","pubTimestamp":1747224002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA52WRN8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CHRO"],"gpt_icon":0},{"id":"2532581770","title":"Press Release: GRAINGER NAMES MELANIE TINTO AS CHIEF HUMAN RESOURCES OFFICER","url":"https://stock-news.laohu8.com/highlight/detail?id=2532581770","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532581770?lang=en_us&edition=fundamental","pubTime":"2025-05-02 19:30","pubTimestamp":1746185400,"startTime":"0","endTime":"0","summary":"CHICAGO, May 2, 2025 /PRNewswire/ -- Grainger , the leading broad line distributor of maintenance, repair and operating  products serving businesses and institutions, today announced the appointment of Melanie Tinto as Senior Vice President, Chief Human Resources Officer , effective April 28. With this appointment, she will join the Grainger Leadership Team and oversee HR strategy and operations, including talent management, succession planning, compensation, organizational performance and benefits.\"As we continue to grow and evolve, it is essential that our most valuable asset--our team members--are supported, engaged, and motivated by strong leadership and a commitment to our principles,\" said D.G. Macpherson, Chairman and CEO. \"Melanie's appointment underscores our commitment to having a culture where every team member has the opportunity to learn, develop and achieve success.\". Melanie joins Grainger from WEX, a financial technology solutions provider, where she served as CHRO. Dur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4232","BK4213","BK4567","IE00B19Z9505.USD","LU0256331488.USD","MRO","R","CHRO","BK4022","BK4597","BK6046","GWW","BK4104","SGR.SI","BK4585","BK4588"],"gpt_icon":0},{"id":"2529683788","title":"Press Release: Angie DeWitt announces her retirement from Associated Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2529683788","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529683788?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:05","pubTimestamp":1745413500,"startTime":"0","endTime":"0","summary":"DeWitt set to step down as chief human resources officer on June 2, 2025. GREEN BAY, Wis., April 23, 2025 /PRNewswire/ -- Associated Banc-Corp   today announced that Chief Human Resources Officer  Angie DeWitt has announced her plans to retire after an exceptional 17-year career with the company.Joining Associated Bank in 2008, DeWitt has been a key member of the bank's executive leadership team, playing a pivotal role in shaping organizational success. She began her career in Finance and advanced to the position of CHRO in 2019.\"Angie's career is a true success story, one that we proudly celebrate,\" said President & CEO Andy Harmening. \"She has been a trusted partner to me since day one. Her legacy is one of lasting impact, shaping not only the workforce we have today, but the foundation on which we'll build for years to come.\". DeWitt will remain with Associated for a period of time as an advisor to assure successful transition of her successor.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","ASB","BK4139","CHRO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chromocell.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.1007},{"period":"1year","weight":0.9594},{"period":"ytd","weight":1.1061}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.","exchange":"NASDAQ","name":"Chromocell Therapeutics Corp","nameEN":"Chromocell Therapeutics Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Chromocell Therapeutics Corp(CHRO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Chromocell Therapeutics Corp(CHRO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Chromocell Therapeutics Corp,CHRO,Chromocell Therapeutics Corp股票,Chromocell Therapeutics Corp股票老虎,Chromocell Therapeutics Corp股票老虎国际,Chromocell Therapeutics Corp行情,Chromocell Therapeutics Corp股票行情,Chromocell Therapeutics Corp股价,Chromocell Therapeutics Corp股市,Chromocell Therapeutics Corp股票价格,Chromocell Therapeutics Corp股票交易,Chromocell Therapeutics Corp股票购买,Chromocell Therapeutics Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Chromocell Therapeutics Corp(CHRO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Chromocell Therapeutics Corp(CHRO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction